2014: a bittersweet but mostly bitter symphony
This article was originally published in Scrip
Executive Summary
2014 is not looking too rosy for the global branded pharmaceutical market as a whole. Continuing pressure from patent expirations, government cost-containment policies in Europe, and weak employment in the US are the key hurdles facing the industry this year, according to a report from Fitch Ratings.